Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Infections 2Soft Tissue Infections 1Neutropenia 1Lymphoma, Follicular 1Hot Flashes 1Hematologic Neoplasms 1Fournier Gangrene 1Fever 1Fasciitis, Necrotizing 1

Interventions

pegfilgrastim 9Filgrastim 6eflapegrastim 3Docetaxel 3Cyclophosphamide 3posaconazole 1plerixafor 1isavuconazole 1ceftobiprole medocaril 1angiotensin I (1-7) 1Vancomycin 1Sodium Chloride 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Levofloxacin 1Itraconazole 1Granulocyte Colony-Stimulating Factor 1Fluconazole 1EC regimen 1Daptomycin 1Cefepime 1Caspofungin 1Bevacizumab 1Algorithms 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neutropenia × Daptomycin × Clear all
NCT00335478 2017-05-09

Daptomycin in Treating Neutropenia and Fever in Patients With Cancer

OHSU Knight Cancer Institute

Phase 2 Completed
54 enrolled 4 charts

Fever, Infections, Neutropenia, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡